OTC Markets Group Welcomes Advaxis, Inc. to OTCQX
/PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for over 11,000 U.S. and global securities, today announced Advaxis, Inc....
Source: prnewswire.com
📰 Tim Mccarthy News
Page 47 - Tim Mccarthy News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Tim Mccarthy. Real-time updates on events, politics, business and more.
Relmada Therapeutics Announces Publication of REL-1017 Phase 2 Study Results in The American Journal of Psychiatry
/PRNewswire/ -- Relmada Therapeutics, Inc. (NASDAQ: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...
United States Paolol Manfredi Sergio Traversa Tim Mccarthy Relmada Therapeutics Inc Clinical Research Program
Source: prnewswire.com
ImmuPharma PLC raises £3.55mln at a significant premium to Friday's share price
The cash injection will be used to fund research and development
Source: proactiveinvestors.co.uk
ImmuPharma raise £3.55m 'giving validation' from Lanstead and Lupuzor partner Avion
ImmuPharma PLC (AIM:IMM, OTC:IMMPF)s (ImmuPharma PLC (AIM:IMM, OTC:IMMPF), ImmuPharma PLC (AIM:IMM, OTC:IMMPF)) chief executive, Tim...
Source: proactiveinvestors.com
ImmuPharma PLC raises £3.55mln at a significant premium to Friday's share price
The cash injection will be used to fund research and development
Source: proactiveinvestors.com
ImmuPharma raise £3.55m 'giving validation' from Lanstead and Lupuzor partner Avion
ImmuPharma PLC (AIM:IMM, OTC:IMMPF)s (ImmuPharma PLC (AIM:IMM, OTC:IMMPF), ImmuPharma PLC (AIM:IMM, OTC:IMMPF)) chief executive, Tim...
Source: proactiveinvestors.co.uk
ImmuPharma raise £3.55m 'giving validation' from Lupuzor partner Avion Pharmaceuticals
ImmuPharma PLC (AIM:IMM, OTC:IMMPF)s (ImmuPharma PLC (AIM:IMM, OTC:IMMPF), ImmuPharma PLC (AIM:IMM, OTC:IMMPF)) chief executive, Tim...
Source: proactiveinvestors.co.uk
ImmuPharma raise £3.55m 'giving validation' from Lupuzor partner Avion Pharmaceuticals
ImmuPharma PLC (AIM:IMM, OTC:IMMPF)s (ImmuPharma PLC (AIM:IMM, OTC:IMMPF), ImmuPharma PLC (AIM:IMM, OTC:IMMPF)) chief executive, Tim...
Source: proactiveinvestors.com
BioLineRx Provides Highlights from Oral Presentation Delivered at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition
/PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical Company focused on oncology, today provided updates from an...
United States Moran Meir Tim Mccarthy American Society Of Hematology Lifesci Advisors Exchange Commission On
Source: prnewswire.com
BioLineRx Provides Highlights from Oral Presentation Delivered at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition
/PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical Company focused on oncology, today provided updates from an...
United States Moran Meir Tim Mccarthy American Society Of Hematology Lifesci Advisors Exchange Commission On
Source: prnewswire.com